Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Apr:30:170-184.
doi: 10.1016/j.clnesp.2018.12.085. Epub 2019 Jan 9.

Vitamin D and breast cancer: A systematic review and meta-analysis of observational studies

Affiliations
Meta-Analysis

Vitamin D and breast cancer: A systematic review and meta-analysis of observational studies

Sharmin Hossain et al. Clin Nutr ESPEN. 2019 Apr.

Abstract

Context: Breast cancer (BC) is the most common malignancy among women in the US. Vitamin D status and intakes are thought to be inversely associated with BC occurrence.

Objectives: In our systematic review and meta-analysis, we evaluated evidence linking serum 25(OH)D (both in serum and diet) with breast cancer (BC) occurrence.

Data sources and extraction: Only observational studies from databases such as PubMed and Cochrane (January 1st 2000 through March 15th, 2018) were included using PRISMA guidelines. Publication bias and consistency upon replication were assessed, while harmonizing risk ratios (RR, 95% CI) of BC, per fixed increment of 5 exposures [10 ng/mL of 25(OH)D; 100 IU/d for total/dietary vitamin D intakes; vitamin D deficiency; supplement use). RRs were pooled using random effect models.

Data analysis: Pooled findings from 22 studies suggested a net direct association between 25(OH)D deficiency and BC, with RRpooled = 1.91, 95% CI: 1.51-2.41, P < 0.001). Total vitamin D intake (RRpooled = 0.99, 95% CI: 0.97-1.00, P = 0.022, per 100 IU/d) and supplemental vitamin D (RRpooled = 0.97, 95% CI:0.95-1.00, P = 0.026) were inversely associated with BC. No evidence of publication bias was found; all 5 exposures of interest were consistent upon replication.

Conclusions: 25(OH)D deficiency was directly related to BC while total vitamin D and supplemental vitamin D intakes had an inverse relationship with this outcome. Randomized clinical trials are warranted pending further evidence from primary meta-analyses of observational studies.

Keywords: Breast cancer; Meta-analysis; Vitamin D.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Flowchart of the study selection of articles reporting vitamin D (or related key terms) in relation to BC, PubMed and Cochrane database search 2000–2018.
Fig. 2.
Fig. 2.
A–B Forest plot of odds ratios with 95% CI of the association between serum 25(OH)D (A) per 10 ng/mL or (B) Deficient vs. not (<10 ng/mL vs. ≥10 ng/mL (referent)) and BC, 2000–2018.
Fig. 3.
Fig. 3.
A–C Forest plot of odds ratios with 95% CI for the associations of (A) total vitamin D (per 100 IU/d) (B) dietary vitamin D (per 100 IU/d) and (C) supplemental (yes vs. no) vitamin D with BC, 2000–2018.

References

    1. Blumen H, Fitch K, Polkus V. Comparison of treatment costs for breast cancer, by tumor stage and type of service. Am Health Drug Benefits 2016;9: 23–32. - PMC - PubMed
    1. Bodnar LM, Catov JM, Wisner KL, Klebanoff MA. Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years. Br J Nutr 2009;101:278–84. - PMC - PubMed
    1. Shi L, Nechuta S, Gao YT, Zheng Y, Dorjgochoo T, Wu J, et al. Correlates of 25-hydroxyvitamin D among Chinese breast cancer patients. PLoS One 2014;9, e86467. - PMC - PubMed
    1. Shaukat N, Jaleel F, Moosa FA, Qureshi NA. Association between vitamin D deficiency and breast cancer. Pak J Med Sci 2017;33:645–9. - PMC - PubMed
    1. Lee MS, Huang YC, Wahlqvist ML, Wu TY, Chou YC, Wu MH, et al. Vitamin D decreases risk of breast cancer in premenopausal women of normal weight in subtropical taiwan. J Epidemiol 2011;21:87–94. - PMC - PubMed

Publication types

MeSH terms